Prostatitis is an inflammation of the prostate gland. This disease can affect men of any age, even the young ones. The cost of treatment depends on the disease type (chronic or acute) and methods of therapy.
Diagnostics is the first step of prostatitis treatment. Price for diagnostics depends on the number of tests a patient need.
After the examinations, a doctor develops a treatment program for each patient. The program includes all types of therapies and medications a patient need. Cost of the treatment program depends on the methods, equipment, and medicines used for patient treatment.
At the advanced stage of prostatitis, doctors prescribe stronger drugs that are more effective.
Also, specialists provide a lot of procedures for patients with advanced prostatitis. So the treatment cost of advanced prostatitis patients will be more expensive than for mild prostatitis patients.
The price for the prostatitis treatment relies on the following factors:
- number of additional examinations and their complexity;
- cost of medicines and procedures;
- clinics’ price list of consultations and accommodation;
- location of the hospital;
- option to choose a particular doctor and the price for his/her services.
All medical content on this page is prepared by authors with specialized medical education and reviewed by certified physicians in the relevant field. Medical review by Fahad Mawlood, Medical Editor & Data Scientist.
Last updated: October 18, 2023.
- Statistics: Figures are based on Bookimed’s internal database December 2025, which includes analysis of 12,450 patient requests across accredited clinics in .
- Pricing: Cost information is provided directly by Bookimed’s partner clinics and updated regularly to reflect current 2025 market conditions. Actual expenses may differ depending on case complexity, surgeon expertise, and clinic location.
- Clinical Data: Treatment outcomes and patient satisfaction figures are collected from Bookimed’s verified clinic database and supported by data from peer-reviewed medical sources such as PubMed, The Lancet, JAMA, and NEJM (2023–2025).
All data is provided for general informational purposes and may not represent individual results or experiences.


